NCT00393666

Brief Summary

Our study examines which different brain regions are involved in child absence seizures and how they are related to attention and cognition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2006

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 30, 2006

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

January 26, 2016

Status Verified

January 1, 2016

Enrollment Period

9 years

First QC Date

October 23, 2006

Last Update Submit

January 25, 2016

Conditions

Childhood Absence Epilepsy

Keywords

AbsenceEpilepsySeizureBrain

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients diagnosed with absence epilepsy

You may qualify if:

  • Confirmed diagnosis of childhood absence epilepsy or juvenile absence epilepsy
  • No other serious health problems or neurological problems
  • years or older

You may not qualify if:

  • No history of myoclonic or tonic-clonic seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University School of Medicine, Neurology Department

New Haven, Connecticut, 06510, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Saliva samples

MeSH Terms

Conditions

Epilepsy, AbsenceEpilepsySeizures

Condition Hierarchy (Ancestors)

Epilepsy, GeneralizedBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic SyndromesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hal Blumenfeld, MD, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

  • Michiro Negishi, PhD

    Diagnostic Radiology

    STUDY DIRECTOR

  • R. Todd Constable, PhD

    Yale University

    STUDY DIRECTOR

  • Jennifer Guo, MS

    Yale University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 23, 2006

First Posted

October 30, 2006

Study Start

September 1, 2006

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

January 26, 2016

Record last verified: 2016-01

Locations

US(1)